Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system

• Published in: Frontiers in immunology Vol. 14; p. 1108682
• Main Authors: Ayoub, Ikram, Dauvilliers, Yves, Barateau, Lucie, Vermeulen, Thaïs, Mouton-Barbosa, Emmanuelle, Marcellin, Marlène, Gonzalez-de-Peredo, Anne, Gross, Catharina C, Saoudi, Abdelhadi, Liblau, Roland
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers 12-04-2023; Frontiers Media S.A
• Subjects: Biochemistry, Molecular Biology; cerebrospinal fluid; coagulation system; complement system; Complement System Proteins; Genomics; Human health and pathology; Humans; Immunology; Innate immunity; Life Sciences; Narcolepsy; narcolepsy type 1; Neurobiology; neuroimmunology; Neurons and Cognition; Orexins; Proteome; Proteomics; Tandem Mass Spectrometry; coagulation system; neuroimmunology; narcolepsy type 1; proteomics; immune response; complement system; cerebrospinal fluid
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2023.1108682

Narcolepsy type 1 (NT1) is a rare, chronic and disabling neurological disease causing excessive daytime sleepiness and cataplexy. NT1 is characterized pathologically by an almost complete loss of neurons producing the orexin neuropeptides in the lateral hypothalamus. Genetic and environmental factors strongly suggest the involvement of the immune system in the loss of orexin neurons. The cerebrospinal fluid (CSF), secreted locally and surrounding the central nervous system (CNS), represents an accessible window into CNS pathological processes.
To gain insight into the biological and molecular changes in NT1 patients, we performed a comparative proteomics analysis of the CSF from 21 recent-onset NT1 patients and from two control groups: group 1 with somatoform disorders, and group 2 patients with hypersomnia other than NT1, to control for any potential effect of sleep disturbances on CSF composition. To achieve an optimal proteomic coverage analysis, the twelve most abundant CSF proteins were depleted, and samples were analyzed by nano-flow liquid chromatography tandem mass spectrometry (nano-LC-MS/MS) using the latest generation of hybrid Orbitrap mass spectrometer.
Our study allowed the identification and quantification of up to 1943 proteins, providing a remarkably deep analysis of the CSF proteome. Interestingly, gene set enrichment analysis indicated that the complement and coagulation systems were enriched and significantly activated in NT1 patients in both cohorts analyzed. Notably, the lectin and alternative complement pathway as well as the downstream lytic membrane attack complex were congruently increased in NT1. Our data suggest that the complement dysregulation in NT1 patients can contribute to immunopathology either by directly promoting tissue damage or as part of local inflammatory responses. We therefore reveal an altered composition of the CSF proteome in NT1 patients, which points to an ongoing inflammatory process contributed, at least in part, by the complement system.